Patrick R. Trucchio
Stock Analyst at HC Wainwright & Co.
(3.04)
# 875
Out of 4,996 analysts
19
Total ratings
100%
Success rate
24.5%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Patrick R. Trucchio
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HRMY Harmony Biosciences Holdings | Maintains: Buy | $70 → $55 | $27.51 | +99.93% | 1 | Sep 25, 2025 | |
| QURE uniQure | Reiterates: Buy | $70 | $54.31 | +28.89% | 3 | Sep 24, 2025 | |
| ATAI Atai Life Sciences | Reiterates: Buy | $15 | $5.27 | +184.63% | 1 | Sep 23, 2025 | |
| SLN Silence Therapeutics | Reiterates: Buy | $75 | $5.54 | +1,253.79% | 1 | Sep 16, 2025 | |
| VIR Vir Biotechnology | Reiterates: Buy | $15 | $5.49 | +173.22% | 1 | Sep 15, 2025 | |
| BEAM Beam Therapeutics | Reiterates: Buy | $80 | $22.97 | +248.28% | 1 | Sep 15, 2025 | |
| VYGR Voyager Therapeutics | Reiterates: Buy | $30 | $4.52 | +563.72% | 1 | Sep 15, 2025 | |
| DRUG Bright Minds Biosciences | Reiterates: Buy | $85 | $52.72 | +61.23% | 2 | Sep 15, 2025 | |
| ALGS Aligos Therapeutics | Reiterates: Buy | $50 | $9.79 | +410.73% | 2 | Sep 12, 2025 | |
| NRXP NRx Pharmaceuticals | Assumes: Buy | $40 | $2.95 | +1,255.93% | 1 | Sep 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $0.66 | +1,406.02% | 1 | Sep 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $570 | $446.40 | +27.69% | 1 | Sep 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $32.80 | +143.90% | 1 | Sep 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.12 | +346.43% | 1 | Aug 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $3.95 | +153.16% | 1 | Aug 18, 2025 |
Harmony Biosciences Holdings
Sep 25, 2025
Maintains: Buy
Price Target: $70 → $55
Current: $27.51
Upside: +99.93%
uniQure
Sep 24, 2025
Reiterates: Buy
Price Target: $70
Current: $54.31
Upside: +28.89%
Atai Life Sciences
Sep 23, 2025
Reiterates: Buy
Price Target: $15
Current: $5.27
Upside: +184.63%
Silence Therapeutics
Sep 16, 2025
Reiterates: Buy
Price Target: $75
Current: $5.54
Upside: +1,253.79%
Vir Biotechnology
Sep 15, 2025
Reiterates: Buy
Price Target: $15
Current: $5.49
Upside: +173.22%
Beam Therapeutics
Sep 15, 2025
Reiterates: Buy
Price Target: $80
Current: $22.97
Upside: +248.28%
Voyager Therapeutics
Sep 15, 2025
Reiterates: Buy
Price Target: $30
Current: $4.52
Upside: +563.72%
Bright Minds Biosciences
Sep 15, 2025
Reiterates: Buy
Price Target: $85
Current: $52.72
Upside: +61.23%
Aligos Therapeutics
Sep 12, 2025
Reiterates: Buy
Price Target: $50
Current: $9.79
Upside: +410.73%
NRx Pharmaceuticals
Sep 8, 2025
Assumes: Buy
Price Target: $40
Current: $2.95
Upside: +1,255.93%
Sep 4, 2025
Reiterates: Buy
Price Target: $10
Current: $0.66
Upside: +1,406.02%
Sep 2, 2025
Reiterates: Buy
Price Target: $570
Current: $446.40
Upside: +27.69%
Sep 2, 2025
Reiterates: Buy
Price Target: $80
Current: $32.80
Upside: +143.90%
Aug 27, 2025
Reiterates: Buy
Price Target: $5
Current: $1.12
Upside: +346.43%
Aug 18, 2025
Reiterates: Buy
Price Target: $10
Current: $3.95
Upside: +153.16%